<?xml version="1.0" encoding="UTF-8"?>
<html><body class="spl" id="spl">
<div class="DocumentTitle"><p class="DocumentTitle"><strong>ARBINOXA- carbinoxamine maleate tablet </strong><br>Hawthorn Pharmaceuticals, Inc.<br></p></div>
<h1>Arbinoxa<span class="Sup">®</span> Tablets<br>(Carbinoxamine Maleate Tablets, USP) <br>4 mg<br>Rx only<br>NDC 63717-870-01</h1>
<div class="Contents">
<div class="Section" data-sectionCode="48780-1">
<a name="section-1"></a><p></p>
</div>
<div class="Section" data-sectionCode="34089-3">
<a name="i4i_description_id_4ea15988-daa3-40e9-af51-c427618e1955"></a><a name="section-1"></a><p></p>
<h1>DESCRIPTION:</h1>
<p class="First">Carbinoxamine maleate is a histamine-H<span class="Sub">1</span> receptor blocking agent.</p>
<p>Each tablet contains 4 mg carbinoxamine maleate and the following inactive ingredients: lactose monohydrate, magnesium stearate, microcrystalline cellulose, and sodium starch glycolate.</p>
<p>Carbinoxamine maleate is freely soluble in water. Its structure is</p>
<div class="Figure"><img alt="Structure" src="http://dailymed.nlm.nih.gov/dailymed/image.cfm?setid=3f4f633c-5c5d-4d52-abb8-dfa2896b40d2&amp;name=1ba6c095-5c85-4d28-959c-45a1b5569e4f-01.jpg"></div>
<p>2-[(4-chlorophenyl)-2-pyridinylmethoxy]-<span class="Italics">N</span>, N<span class="Italics">-dimethylethanamine</span> (Z)-2-butenedioate (1:1)</p>
<p>C<span class="Sub">16</span>H<span class="Sub">19</span>ClN<span class="Sub">2</span>O•C<span class="Sub">4</span>H<span class="Sub">4</span>O<span class="Sub">4</span>                    MW = 406.86</p>
</div>
<div class="Section" data-sectionCode="34090-1">
<a name="i4i_clinical_pharmacology_id_1faa4d43-6a82-43e0-a39e-dde49deda4bb"></a><a name="section-2"></a><p></p>
<h1>CLINICAL PHARMACOLOGY:</h1>
<p class="First">Carbinoxamine maleate is an antihistamine with anticholinergic (drying) and sedative properties. Antihistamines appear to compete with histamine for receptor sites on effector cells.</p>
<p>The pharmacological effects of carbinoxamine maleate after oral absorption have been shown to last approximately 4 hours. </p>
<p>Interactions of carbinoxamine maleate with food or with other drugs and the possibility of cardiac conduction effects on the QT interval have not been studied.</p>
</div>
<div class="Section" data-sectionCode="34067-9">
<a name="i4i_indications_id_74c6a149-0309-4235-b7a2-84cf0d543769"></a><a name="section-3"></a><p></p>
<h1>INDICATIONS AND USAGE:</h1>
<p class="First">Carbinoxamine maleate is effective for the symptomatic treatment of:</p>
<p>Seasonal and <span class="product-label-link" type="condition" conceptid="40486433" conceptname="Perennial allergic rhinitis">perennial allergic rhinitis</span>.</p>
<p><span class="product-label-link" type="condition" conceptid="4305500" conceptname="Vasomotor rhinitis">Vasomotor rhinitis</span>.</p>
<p><span class="product-label-link" type="condition" conceptid="374959" conceptname="Contact blepharoconjunctivitis">Allergic conjunctivitis</span> due to inhalant allergens and foods.</p>
<p>Mild, uncomplicated allergic skin manifestations of <span class="product-label-link" type="condition" conceptid="139900" conceptname="Urticaria">urticaria</span> and <span class="product-label-link" type="condition" conceptid="432791" conceptname="Angioedema">angioedema</span>.</p>
<p>Dermatographism.</p>
<p>As therapy for <span class="product-label-link" type="condition" conceptid="441202" conceptname="Anaphylaxis">anaphylactic reactions</span> <span class="Italics">adjunctive</span> to epinephrine and other standard measures after the acute manifestations have been controlled.</p>
<p>Amelioration of the severity of <span class="product-label-link" type="condition" conceptid="4084167" conceptname="Acute allergic reaction">allergic reactions</span> to blood or plasma.</p>
</div>
<div class="Section" data-sectionCode="34070-3">
<a name="i4i_contraindications_id_ecbb414b-7206-4148-84a4-83938832df26"></a><a name="section-4"></a><p></p>
<h1>CONTRAINDICATIONS:</h1>
<p class="First">Carbinoxamine maleate is contraindicated in children younger than 2 years of age.</p>
<p>Carbinoxamine maleate is contraindicated in nursing mothers.</p>
<p>Carbinoxamine maleate is contraindicated in patients who are hypersensitive to the drug or on monoamine oxidase inhibitor therapy. (See <span class="Underline"><a href="#i4i_interactions_id_ec7735d9-e4f7-476f-b9b2-3265abf8296e">Drug Interactions</a></span> section.)</p>
</div>
<div class="Section" data-sectionCode="34071-1">
<a name="i4i_warnings_id_64209a8f-2a16-44d1-99e9-63ecb3b4e8f7"></a><a name="section-5"></a><p></p>
<h1>WARNINGS:</h1>
<p class="First"><span class="product-label-link" type="condition" conceptid="4306655" conceptname="Death">Deaths</span> have been reported in children less than 2 years of age who were taking antihistamines, including carbinoxamine-containing drug products, therefore, carbinoxamine maleate is contraindicated in children younger than 2 years of age (see <span class="Underline"><a href="#i4i_contraindications_id_ecbb414b-7206-4148-84a4-83938832df26">CONTRAINDICATIONS</a></span>). </p>
<p>Antihistamines should be used with considerable caution in patients with: narrow angle <span class="product-label-link" type="condition" conceptid="437541" conceptname="Glaucoma">glaucoma</span>, stenosing <span class="product-label-link" type="condition" conceptid="4027663" conceptname="Peptic ulcer">peptic ulcer</span>, symptomatic <span class="product-label-link" type="condition" conceptid="198803" conceptname="Benign prostatic hyperplasia">prostatic hypertrophy</span>, <span class="product-label-link" type="condition" conceptid="433813" conceptname="Bladder neck obstruction">bladder neck obstruction</span>, pyloroduodenal obstruction.</p>
</div>
<div class="Section" data-sectionCode="42232-9">
<a name="i4i_precautions_id_961e78db-37f2-4ad2-9424-536ea369a5c3"></a><a name="section-6"></a><p></p>
<h1>PRECAUTIONS:</h1>
<div class="Section" data-sectionCode="34072-9">
<a name="i4i_precautions_general_id_01cd9ab8-8137-4cd0-92a2-6b022434eb90"></a><a name="section-6.1"></a><p></p>
<h2>General:</h2>
<p class="First">As with many other antihistamines, carbinoxamine maleate has an atropine-like action and, therefore, should be used with caution in patients with: <span class="product-label-link" type="condition" conceptid="4011560" conceptname="Raised intraocular pressure">increased intraocular pressure</span>, <span class="product-label-link" type="condition" conceptid="4142479" conceptname="Hyperthyroidism">hyperthyroidism</span>, cardiovascular disease, <span class="product-label-link" type="condition" conceptid="316866" conceptname="Hypertensive disorder">hypertension</span>.</p>
<p>Antihistamines such as carbinoxamine maleate should not be used to treat lower respiratory tract symptoms, including <span class="product-label-link" type="condition" conceptid="317009" conceptname="Asthma">asthma</span>.</p>
</div>
<div class="Section" data-sectionCode="34076-0">
<a name="i4i_info_patients_id_00044535-e4d5-4fc2-b2f9-608182b6e791"></a><a name="section-6.2"></a><p></p>
<h2>Information for Patients:</h2>
<p class="First">Carbinoxamine maleate may cause <span class="product-label-link" type="condition" conceptid="4196193" conceptname="Drowsiness">drowsiness</span>; alcohol, sedatives, and tranquilizers may increase the <span class="product-label-link" type="condition" conceptid="4196193" conceptname="Drowsiness">drowsiness</span> effect. Avoid alcoholic beverages while taking this product. Do not take this product if you are taking sedatives or tranquilizers, without first consulting your doctor. Use caution when driving a motor vehicle or operating machinery.</p>
</div>
<div class="Section" data-sectionCode="34073-7">
<a name="i4i_interactions_id_ec7735d9-e4f7-476f-b9b2-3265abf8296e"></a><a name="section-6.3"></a><p></p>
<h2>Drug Interactions:</h2>
<p class="First">Monoamine oxidase inhibitors prolong and intensify the anticholinergic (drying) effects of antihistamines.</p>
<p>Carbinoxamine maleate has additive effects with alcohol and other CNS depressants (hypnotics, sedatives, tranquilizers, etc.).</p>
</div>
<div class="Section" data-sectionCode="34083-6">
<a name="i4i_carcinogenesis_mutagenesis_fertility_id_7ee6563a-2317-4a2d-a86e-0b09106f47e8"></a><a name="section-6.4"></a><p></p>
<h2>Carcinogenesis, Mutagenesis, Impairment of Fertility:</h2>
<p class="First">No long-term studies in animals have been performed to determine the possible effects of carbinoxamine maleate on carcinogenesis, mutagenesis, and fertility.</p>
</div>
<div class="Section" data-sectionCode="42228-7">
<a name="i4i_pregnancy_id_9a18bec0-e0a4-4031-b213-a1033d5039bd"></a><a name="section-6.5"></a><p></p>
<h2>Pregnancy:</h2>
<div class="Section" data-sectionCode="42229-5">
<a name="i4i_section_id_f9717510-2838-414d-b821-24576c69598f"></a><a name="section-6.5.1"></a><p></p>
<h3>Pregnancy Category C:</h3>
<p class="First">Animal reproductive studies have not been conducted with carbinoxamine maleate. It is also not known whether carbinoxamine maleate can cause fetal harm when administered to a pregnant woman or can affect reproductive capacity. Carbinoxamine maleate should be given to a pregnant woman only if clearly needed.</p>
</div>
</div>
<div class="Section" data-sectionCode="34080-2">
<a name="i4i_nursing_mothers_id_c2e7c339-b649-442e-8cda-7e2003492ac2"></a><a name="section-6.6"></a><p></p>
<h2>Nursing Mothers:</h2>
<p class="First">Because of the higher risk of antihistamines for infants generally and for newborns and prematures in particular, use of carbinoxamine maleate is contraindicated in nursing mothers. (see <span class="Underline"><a href="#i4i_contraindications_id_ecbb414b-7206-4148-84a4-83938832df26">CONTRAINDICATIONS</a></span> section).</p>
</div>
<div class="Section" data-sectionCode="34081-0">
<a name="i4i_pediatric_use_id_9ad73c64-e32a-4bc3-9d9a-7ea20862eb5c"></a><a name="section-6.7"></a><p></p>
<h2>Pediatric Use:</h2>
<p class="First">Carbinoxamine maleate is contraindicated in children younger than 2 years of age (see <span class="Underline"><a href="#i4i_contraindications_id_ecbb414b-7206-4148-84a4-83938832df26">CONTRAINDICATIONS</a></span>).</p>
<p>Carbinoxamine maleate may diminish mental alertness in children. In the young child, particularly, they may produce excitation.</p>
</div>
<div class="Section" data-sectionCode="34082-8">
<a name="i4i_geriatric_use_id_ce56e4a1-615b-4de4-8e91-cc7b973c4054"></a><a name="section-6.8"></a><p></p>
<h2>Geriatric Use:</h2>
<p class="First">Carbinoxamine maleate is more likely to cause <span class="product-label-link" type="condition" conceptid="4223938" conceptname="Dizziness">dizziness</span>, sedation, and <span class="product-label-link" type="condition" conceptid="316447" conceptname="Chronic hypotension">hypotension</span> in elderly patients (approximately 60 years or older). Sedating drugs may also cause <span class="product-label-link" type="condition" conceptid="381273" conceptname="Confusional state">confusion</span> and over sedation in the elderly. Therefore, dose selection for an elderly patient should be cautious, usually starting at the low end of the dosing range, reflecting the greater frequency of decreased hepatic renal, or cardiac function, and of concomitant disease or other drug therapy.</p>
</div>
</div>
<div class="Section" data-sectionCode="34084-4">
<a name="i4i_adverse_effects_id_b886004b-df4d-4561-b67c-af6136c72e34"></a><a name="section-7"></a><p></p>
<h1>ADVERSE REACTIONS:</h1>
<p class="First">The most frequent adverse reactions are underlined:</p>
<p><span class="Italics">Body as a Whole:</span>   <span class="product-label-link" type="condition" conceptid="139900" conceptname="Urticaria">Urticaria</span>, <span class="product-label-link" type="condition" conceptid="4080559" conceptname="Baboon syndrome">drug rash</span>, <span class="product-label-link" type="condition" conceptid="441202" conceptname="Anaphylaxis">anaphylactic shock</span>, <span class="product-label-link" type="condition" conceptid="4080920" conceptname="Phytophotodermatitis">photosensitivity</span>, excessive perspiration, <span class="product-label-link" type="condition" conceptid="4190045" conceptname="Rigor">chills</span>, dryness of mouth, nose and throat.</p>
<p><span class="Italics">Cardiovascular:</span>   <span class="product-label-link" type="condition" conceptid="316447" conceptname="Chronic hypotension">Hypotension</span>, <span class="product-label-link" type="condition" conceptid="378253" conceptname="Headache">headache</span>, <span class="product-label-link" type="condition" conceptid="315078" conceptname="Palpitations">palpitations</span>, <span class="product-label-link" type="condition" conceptid="315643" conceptname="Tachyarrhythmia">tachycardia</span>, <span class="product-label-link" type="condition" conceptid="316429" conceptname="Premature beats">extrasystoles</span>.</p>
<p><span class="Italics">Hematologic:</span>   <span class="product-label-link" type="condition" conceptid="435503" conceptname="Hemolytic anemia">Hemolytic anemia</span>, <span class="product-label-link" type="condition" conceptid="432870" conceptname="Thrombocytopenic disorder">thrombocytopenia</span>, <span class="product-label-link" type="condition" conceptid="440689" conceptname="Agranulocytosis">agranulocytosis</span>.</p>
<p><span class="Italics">Central Nervous System:</span>   <span class="Underline">Sedation</span>, <span class="Underline"><span class="product-label-link" type="condition" conceptid="4196193" conceptname="Drowsiness">sleepiness</span></span>, <span class="Underline"><span class="product-label-link" type="condition" conceptid="4223938" conceptname="Dizziness">dizziness</span></span>, <span class="Underline">disturbed coordination</span>, <span class="product-label-link" type="condition" conceptid="4223659" conceptname="Fatigue">fatigue</span>, <span class="product-label-link" type="condition" conceptid="381273" conceptname="Confusional state">confusion</span>, <span class="product-label-link" type="condition" conceptid="4012381" conceptname="Restlessness">restlessness</span>, excitation, <span class="product-label-link" type="condition" conceptid="436817" conceptname="Feeling nervous">nervousness</span>, <span class="product-label-link" type="condition" conceptid="443782" conceptname="Tremor">tremor</span>, <span class="product-label-link" type="condition" conceptid="4184149" conceptname="Feeling irritable">irritability</span>, <span class="product-label-link" type="condition" conceptid="436962" conceptname="Insomnia">insomnia</span>, <span class="product-label-link" type="condition" conceptid="4142453" conceptname="Feeling high">euphoria</span>, <span class="product-label-link" type="condition" conceptid="4193492" conceptname="Acroparesthesia">paresthesia</span>, <span class="product-label-link" type="condition" conceptid="4079185" conceptname="Hazy vision">blurred vision</span>, <span class="product-label-link" type="condition" conceptid="373474" conceptname="Diplopia">diplopia</span>, <span class="product-label-link" type="condition" conceptid="439383" conceptname="Vertigo">vertigo</span>, <span class="product-label-link" type="condition" conceptid="377575" conceptname="Tinnitus">tinnitus</span>, acute <span class="product-label-link" type="condition" conceptid="74052" conceptname="Labyrinthitis">labyrinthitis</span>, <span class="product-label-link" type="condition" conceptid="434889" conceptname="Dissociative disorder">hysteria</span>, <span class="product-label-link" type="condition" conceptid="444252" conceptname="Neuritis">neuritis</span>, <span class="product-label-link" type="condition" conceptid="377091" conceptname="Seizure">convulsions</span>.</p>
<p><span class="Italics">Gastrointestinal:</span>   <span class="Underline"><span class="product-label-link" type="condition" conceptid="23325" conceptname="Heartburn">Epigastric distress</span></span>, <span class="product-label-link" type="condition" conceptid="442165" conceptname="Loss of appetite">anorexia</span>, <span class="product-label-link" type="condition" conceptid="31967" conceptname="Nausea">nausea</span>, <span class="product-label-link" type="condition" conceptid="441408" conceptname="Vomiting">vomiting</span>, <span class="product-label-link" type="condition" conceptid="80141" conceptname="Functional diarrhea">diarrhea</span>, <span class="product-label-link" type="condition" conceptid="75860" conceptname="Constipation">constipation</span>.</p>
<p><span class="Italics">Urogenital:</span>   <span class="product-label-link" type="condition" conceptid="4012368" conceptname="Increased frequency of urination">Urinary frequency</span>, difficult urination, <span class="product-label-link" type="condition" conceptid="192450" conceptname="Retention of urine">urinary retention</span>, early menses.</p>
<p><span class="Italics">Respiratory:</span>   <span class="Underline">Thickenings of bronchial secretions</span>, tightness of chest and <span class="product-label-link" type="condition" conceptid="314754" conceptname="Wheezing">wheezing</span>, <span class="product-label-link" type="condition" conceptid="4195085" conceptname="Nasal congestion">nasal stuffiness</span>.</p>
</div>
<div class="Section" data-sectionCode="34088-5">
<a name="i4i_overdosage_id_b7099f79-d57b-44c0-9a63-75c058cf0c19"></a><a name="section-8"></a><p></p>
<h1>OVERDOSAGE:</h1>
<div class="Section" data-sectionCode="42229-5">
<a name="i4i_section_id_ee67610c-43c1-496c-91d1-984656d10865"></a><a name="section-8.1"></a><p></p>
<h2>Manifestations:</h2>
<p class="First">Antihistamine overdosage reactions may vary from central nervous system <span class="product-label-link" type="condition" conceptid="438727" conceptname="Atypical depressive disorder">depression</span> to stimulation. Stimulation is particularly likely in children. Atropine-like signs and symptoms - <span class="product-label-link" type="condition" conceptid="4226991" conceptname="Aptyalism">dry mouth</span>; fixed, <span class="product-label-link" type="condition" conceptid="4290615" conceptname="Dilated pupil">dilated pupils</span>; <span class="product-label-link" type="condition" conceptid="318566" conceptname="Flushing">flushing</span>; and <span class="product-label-link" type="condition" conceptid="4302537" conceptname="Digestive system finding">gastrointestinal symptoms</span> may also occur.</p>
<p>Especially in infants and children, antihistamine overdosage may cause <span class="product-label-link" type="condition" conceptid="433031" conceptname="Hallucinations">hallucinations</span>, <span class="product-label-link" type="condition" conceptid="377091" conceptname="Seizure">convulsions</span>, or <span class="product-label-link" type="condition" conceptid="4306655" conceptname="Death">death</span>. </p>
<p>The oral LD<span class="Sub">50</span> of carbinoxamine maleate in guinea pigs is 411 mg/kg.</p>
</div>
<div class="Section" data-sectionCode="42229-5">
<a name="i4i_section_id_16ea2779-2607-44eb-ad15-5fcfdf5e081e"></a><a name="section-8.2"></a><p></p>
<h2>Treatment:</h2>
<p class="First">The treatment of overdosage with carbinoxamine maleate is essentially symptomatic and supportive. Vital signs (including respiration, pulse, blood pressure, and temperature) and EKG should be monitored. Induction of <span class="product-label-link" type="condition" conceptid="441408" conceptname="Vomiting">vomiting</span> is not recommended. Activated charcoal should be given and gastric lavage should be considered after ingestion of a potentially life-threatening amount of drug. In the presence of severe anticholinergic effects, physostigmine may be useful. Vasopressors may be used to treat <span class="product-label-link" type="condition" conceptid="316447" conceptname="Chronic hypotension">hypotension</span>.</p>
</div>
</div>
<div class="Section" data-sectionCode="34068-7">
<a name="i4i_dosage_admin_id_f2c4acf9-b859-41f3-83ee-d14b8a6a485c"></a><a name="section-9"></a><p></p>
<h1>DOSAGE AND ADMINISTRATION:</h1>
<p class="First">Carbinoxamine maleate is contraindicated in children younger than 2 years of age (see <span class="Underline"><a href="#i4i_contraindications_id_ecbb414b-7206-4148-84a4-83938832df26">CONTRAINDICATIONS</a></span>).</p>
<p>Carbinoxamine maleate should be taken on an empty stomach with water.</p>
<p>DOSAGE SHOULD BE INDIVIDUALIZED ACCORDING TO THE NEEDS AND THE RESPONSE OF THE PATIENT.</p>
<p>Carbinoxamine maleate dosage should be based on the severity of the condition and the response of the patient. The drug is well tolerated in doses as high as 24 mg daily, in divided doses, over <span class="product-label-link" type="condition" conceptid="4088438" conceptname="Prolonged periods">prolonged periods</span>. On the other hand, some patients respond to as little as 4 mg daily.</p>
<p>Clinical experience suggests the following dosage schedules:</p>
<p><span class="Bold"><span class="Italics">Tablets</span></span></p>
<p>Usual Adult Dosage:</p>
<ul><li>1 or 2 tablets (4 to 8 mg) 3 to 4 times daily</li></ul>
<p>Usual Child's Dosage:</p>
<ul><li>Six to eleven years—1/2 to 1 tablet (2 to 4 mg) 3 or 4 times daily.</li></ul>
</div>
<div class="Section" data-sectionCode="34069-5">
<a name="i4i_how_supplied_id_93bfd49a-0fbe-49af-ac48-ea7df5e9e5f1"></a><a name="section-10"></a><p></p>
<h1>HOW SUPPLIED:</h1>
<p class="First">Arbinoxa Tablets (Carbinoxamine Maleate Tablets, USP) 4 mg are supplied as white, round, scored tablets, debossed "CYP 870" on one side and scored on the other, and are supplied in bottles of 100 tablets, NDC 63717-870-01. </p>
<p>Store at 20° to 25°C (68° to 77°F) [See USP controlled room temperature.]</p>
<p>Dispense in a tight, light-resistant container with a child-resistant closure as defined in the official compendium.</p>
<p><span class="Bold">To report SUSPECTED ADVERSE REACTIONS, contact Pernix Therapeutics, LLC. at 1-877-745-3667 or FDA at 1-800-FDA-1088 or www.fda.gov/medwatch.</span></p>
<p><span class="Bold">Manufactured for:</span></p>
<p>Hawthorn Pharmaceuticals, Inc.<br>Morristown, NJ 07960</p>
<p>Rev. 08/15<br>HL215</p>
</div>
<div class="Section" data-sectionCode="51945-4">
<a name="i4i_Principal_display_panel_id_266d1058-f31c-41b6-8967-1a8f277bf979"></a><a name="section-11"></a><p></p>
<h1>PRINCIPAL DISPLAY PANEL - 4 mg Bottle Label</h1>
<p class="First"><span class="Bold">NDC 63717-870-01</span></p>
<p><span class="Bold">Arbinoxa</span><span class="Sup">®</span><br><span class="Bold">Tablets</span><br>(Carbinoxamine Maleate Tablets, USP)</p>
<p>4 mg<br>Rx Only</p>
<p><span class="Bold">HAWTHORN<br>PHARMACEUTICALS, INC.</span></p>
<p>100 Tablets</p>
<div class="Figure"><img alt="PRINCIPAL DISPLAY PANEL - 4 mg Bottle Label" src="http://dailymed.nlm.nih.gov/dailymed/image.cfm?setid=3f4f633c-5c5d-4d52-abb8-dfa2896b40d2&amp;name=arbinoxa-02.jpg"></div>
</div>
</div>
<div class="DataElementsTables">
<table class="contentTablePetite" cellSpacing="0" cellPadding="3" width="100%"><tbody>
<tr><td class="contentTableTitle">
<strong>ARBINOXA 		
					</strong><br><span class="contentTableReg">carbinoxamine maleate tablet</span>
</td></tr>
<tr><td><table width="100%" cellpadding="5" cellspacing="0" class="formTablePetite">
<tr><td colspan="4" class="formHeadingTitle">Product Information</td></tr>
<tr class="formTableRowAlt">
<td class="formLabel">Product Type</td>
<td class="formItem">HUMAN PRESCRIPTION DRUG LABEL</td>
<td class="formLabel">Item Code (Source)</td>
<td class="formItem">NDC:63717-870</td>
</tr>
<tr class="formTableRow">
<td width="30%" class="formLabel">Route of Administration</td>
<td class="formItem">ORAL</td>
<td width="30%" class="formLabel">DEA Schedule</td>
<td class="formItem">    
							</td>
</tr>
</table></td></tr>
<tr><td><table width="100%" cellpadding="3" cellspacing="0" class="formTablePetite">
<tr><td colspan="3" class="formHeadingTitle">Active Ingredient/Active Moiety</td></tr>
<tr>
<th class="formTitle" scope="col">Ingredient Name</th>
<th class="formTitle" scope="col">Basis of Strength</th>
<th class="formTitle" scope="col">Strength</th>
</tr>
<tr class="formTableRowAlt">
<td class="formItem">
<strong>CARBINOXAMINE MALEATE</strong> (CARBINOXAMINE) </td>
<td class="formItem">CARBINOXAMINE MALEATE</td>
<td class="formItem">4 mg</td>
</tr>
</table></td></tr>
<tr><td><table width="100%" cellpadding="3" cellspacing="0" class="formTablePetite">
<tr><td colspan="2" class="formHeadingTitle">Inactive Ingredients</td></tr>
<tr>
<th class="formTitle" scope="col">Ingredient Name</th>
<th class="formTitle" scope="col">Strength</th>
</tr>
<tr class="formTableRowAlt">
<td class="formItem"><strong>LACTOSE MONOHYDRATE</strong></td>
<td class="formItem"> </td>
</tr>
<tr class="formTableRow">
<td class="formItem"><strong>MAGNESIUM STEARATE</strong></td>
<td class="formItem"> </td>
</tr>
<tr class="formTableRowAlt">
<td class="formItem"><strong>CELLULOSE, MICROCRYSTALLINE</strong></td>
<td class="formItem"> </td>
</tr>
<tr class="formTableRow">
<td class="formItem"><strong>SODIUM STARCH GLYCOLATE TYPE A POTATO</strong></td>
<td class="formItem"> </td>
</tr>
</table></td></tr>
<tr><td><table width="100%" cellpadding="3" cellspacing="0" class="formTablePetite">
<tr><td colspan="4" class="formHeadingTitle">Product Characteristics</td></tr>
<tr class="formTableRowAlt">
<td class="formLabel">Color</td>
<td class="formItem">WHITE</td>
<td class="formLabel">Score</td>
<td class="formItem">2 pieces</td>
</tr>
<tr class="formTableRow">
<td class="formLabel">Shape</td>
<td class="formItem">ROUND</td>
<td class="formLabel">Size</td>
<td class="formItem">7mm</td>
</tr>
<tr class="formTableRowAlt">
<td class="formLabel">Flavor</td>
<td class="formItem"></td>
<td class="formLabel">Imprint Code</td>
<td class="formItem">CYP;870</td>
</tr>
<tr class="formTableRow">
<td class="formLabel">Contains</td>
<td class="formItem">    </td>
</tr>
</table></td></tr>
<tr><td><table width="100%" cellpadding="3" cellspacing="0" class="formTablePetite">
<tr><td colspan="5" class="formHeadingTitle">Packaging</td></tr>
<tr>
<th scope="col" width="1" class="formTitle">#</th>
<th scope="col" class="formTitle">Item Code</th>
<th scope="col" class="formTitle">Package Description</th>
<th scope="col" class="formTitle">Marketing Start Date</th>
<th scope="col" class="formTitle">Marketing End Date</th>
</tr>
<tr class="formTableRowAlt">
<th scope="row" class="formItem">1</th>
<td class="formItem">NDC:63717-870-01</td>
<td class="formItem">100  in 1 BOTTLE, PLASTIC; Combination Product Type = C112160</td>
<td class="formItem"></td>
<td class="formItem"></td>
</tr>
</table></td></tr>
<tr><td></td></tr>
<tr><td class="normalizer"><table width="100%" cellpadding="3" cellspacing="0" class="formTableMorePetite">
<tr><td colspan="4" class="formHeadingReg"><span class="formHeadingTitle">Marketing Information</span></td></tr>
<tr>
<th scope="col" class="formTitle">Marketing Category</th>
<th scope="col" class="formTitle">Application Number or Monograph Citation</th>
<th scope="col" class="formTitle">Marketing Start Date</th>
<th scope="col" class="formTitle">Marketing End Date</th>
</tr>
<tr class="formTableRowAlt">
<td class="formItem">ANDA</td>
<td class="formItem">ANDA090417</td>
<td class="formItem">08/23/2010</td>
<td class="formItem"></td>
</tr>
</table></td></tr>
</tbody></table>
<table width="100%" cellpadding="3" cellspacing="0" class="formTableMorePetite"><tr><td colspan="4" class="formHeadingReg">
<span class="formHeadingTitle">Labeler - </span>Hawthorn Pharmaceuticals, Inc.
							(118049704)
						</td></tr></table>
</div>
<p><div class="EffectiveDate">Revised: 8/2015<div class="DocumentMetadata">
<div>
<a href="javascript:toggleMixin();">Document Id: </a>b4eb5360-de1b-4a12-8ab5-4271bbb799dc</div>
<div>Set id: 3f4f633c-5c5d-4d52-abb8-dfa2896b40d2</div>
<div>Version: 5</div>
<div>Effective Time: 20150828</div>
</div>
</div> <div class="DistributorName">Hawthorn Pharmaceuticals, Inc.</div></p>
</body></html>
